Cancer Research and Statistics Foundation has been established with the goal of improving the outcome of cancer. This foundation has been active to promote the academic activities related to cancer. There have been multiple activities by the foundation to update the information regarding cancer treatment among oncologists. This foundation organizes workshops to train people in research activities. Foundation participates in academic activities for general physicians. This foundation also helps in the publication of the journal, Cancer Research Statistics and Treatment™ (CRST) and increases awareness about cancer in society.
About the Journal
Cancer Research, and Statistics and TreatmentFoundation (CRSTRSF) is a peer-reviewed journal. It is a Quarterly, open-access, peer-reviewed journal. The journal will cover technical and clinical studies related to health, ethical and social issues in the field of Cancer research, statistics, and treatment. CRST aims to become the most credible, authoritative resource for disseminating significant research findings in clinical oncology, statistics in oncology and translational research.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data, DOAJ
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print models are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
“Pop-up” and “banner” ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
The Editorial Board has full and final approval over the content of all advertisements.
Advertisers will never be shown any manuscripts or other content prior to publication.
Scope of the Journal
The journal will cover technical and clinical studies related to health, ethical and social issues in field of Cancer research, statistics, and treatment aims to become the most credible, authoritative resource for disseminating significant research findings in clinical oncology, statistics in oncology and translational research..
Articles with clinical interest and implications will be given preference.